Efficacy of Probiotics in Preventing Chemotherapy-Induced Diarrhea in Gastrointestinal Cancer Patients

In this study we aimed to evaluate the efficacy of probiotics in prevention of chemotherapy induced diarrhea among patients with gastrointestinal cancer. A total of 28 patients diagnosed with gastrointestinal cancer who were intended to receive chemotherapy based on fluoropyrimidine, oxaliplatin, and/or irinotecan were randomized in a ratio 1:1 to receive either a placebo or probiotic. Patients were instructed to take the product orally once daily for 90 days and to record their bowel habits in a diary using the Bristol stool scale. In this dataset are the collected data from the 28 recruited patients.